Showing 6571-6580 of 18631 results for "".
Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
https://reachmd.com/programs/cme/tailoring-first-line-regimens-patient-centric-selection-in-metastatic-escc/33030/Explore emerging data, guideline recommendations, and AE management for first-line anti-PD-1 and chemotherapy regimens in metastatic ESCC.How the COVID-19 Pandemic Exposed Gaps in US Hospital Preparedness
https://reachmd.com/programs/clinicians-roundtable/how-the-covid-19-pandemic-exposed-gaps-in-us-hospital-preparedness/36413/Hospitals were especially vulnerable during the COVID-19 pandemic, with regulatory barriers, a lack of resources, and disjointed communication compounding the burden of the disease. Tune in to hear Dr. Amesh Adaljia examine the structural and systemic challenges to pandemic preparedness and discussEvolving Treatments: A Review of What’s in the Pipeline
https://reachmd.com/programs/lipid-luminations/evolving-treatments-a-review-of-whats-in-the-pipeline/6630/Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in todThe 2 Overlooked Truths Reshaping the Future of Aesthetic Medicine
https://modernaesthetics.com/ma-issues-index/jan-feb-2026-issue/the-2-overlooked-truths-reshaping-the-future-of-aesthetic-medicine/54439/Honoring Age with Science and Strategy
https://modernaesthetics.com/ma-issues-index/july-august-2025/honoring-age-science-strategy/36655/Mature beauty is not a consolation prize. It is an architectural project that honors decades of expression and experience. Diagnose every layer, match modality to mechanism, and remind your patient that elegance at 80 is never accidental. It is engineered.Coming & Going: November/December 2022
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/coming-going-novemberdecember-2022/35236/SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
https://reachmd.com/programs/heart-matters/select-trial-semaglutide-lowers-cvd-risk-in-patients-with-obesity/16173/A new study shows the potential of semaglutide for lowering cardiovascular disease risk in patients with obesity. Here are the findings from SELECT.Treatment of Developmental/Epileptic Encephalopathy With Spike-Wave Activation in Sleep
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/treatment-of-developmentalepileptic-encephalopathy-with-spike-wave-activation-in-sleep/39968/Developmental/epileptic encephalopathy with spike-wave activation in sleep is a unique electroclinical entity accompanied by cognitive, developmental, or behavioral stagnation or regression.Epilepsy Essentials: Ketogenic Diet Therapy Considerations in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-ketogenic-diet-therapy-considerations-in-clinical-practice/32092/Clinicians need to work closely with people on the ketogenic diet to manage side effects, ensure adequate nutrition, and confirm appropriate seizure control.Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
https://reachmd.com/programs/cme/advances-in-managing-neuropsychiatric-symptoms-of-alzheimers-disease-from-early-detection-to-emerging-therapies/35729/Learn about the diagnosis of NPS associated with Alzheimer’s disease and explore current and emerging treatment options.